SCHEMBL4255202

SCHEMBL4255202

C[C@H](CNC(=O)c1cc2ccccc2o1)Oc1ccc(C(=S)NO)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
TP53 P04637 3/20 0.53
MAPT P10636 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 2/20 0.47
TSHR P16473 3/20 0.47
HPGD P15428 2/20 0.47
MAPK1 P28482 2/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
CASP3 P42574 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
HDAC1 Q13547 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL444394 0.91 SMN1; SMN2 (0.56) SMN1; SMN2TP53MAPTL3MBTL1MEN1
SCHEMBL444395 0.91 SMN1; SMN2 (0.56) SMN1; SMN2TP53MAPTL3MBTL1MEN1
SCHEMBL4255394 0.85 TAS1R3 (0.44) SMN1; SMN2TP53MAPTL3MBTL1TSHR
SCHEMBL4247914 0.82 ALDH1A1 (0.45) SMN1; SMN2TP53MAPTL3MBTL1MEN1
SCHEMBL4248039 0.81 HDAC3 (0.39) SMN1; SMN2TP53MAPTL3MBTL1HDAC1
SCHEMBL4247735 0.81 HPGD (0.73) SMN1; SMN2TP53MAPTL3MBTL1MEN1
SCHEMBL4249839 0.80 ADAM17 (0.44) L3MBTL1MEN1KMT2ATSHRHDAC1
SCHEMBL4251140 0.80 HPGD (0.69) SMN1; SMN2TP53MEN1KMT2ATDP1
SCHEMBL4254728 0.79 HRH3 (0.38) L3MBTL1MEN1KMT2AHDAC1HDAC2
SCHEMBL17254439 0.78 HDAC3 (0.51) SMN1; SMN2TP53MAPTTDP1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023798-A1 THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023798-A1 THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC8, HDAC3 SMN1; SMN2 3469/4885TP53 2008/4885MAPT 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.